Two Cases of Drug-Induced Psoriasis from Second Generation Androgen Receptor Blockers

This is two cases of Androgen-Receptor Induced Psoriasis. Both cases ultimately continued the medications due to risk/benefit analysis by multidisciplinary teams. Both cases also improved with topical ultrapotent steroids. This is the first case series reported to show androgen receptor inhibitors implicated as a class in psoriatic drug eruptions.